PAK4 signaling in health and disease: defining the PAK4–CREB axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PAK4 signaling in health and disease: defining the PAK4–CREB axis

Published:2019-02 Issue:2 Volume:51 Page:1-9
ISSN:1226-3613
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Won So-Yoon,Park Jung-Jin,Shin Eun-Young,Kim Eung-Gook

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/s12276-018-0204-0.pdf

Reference107 articles.

1. Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. & Lim, L. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40–46 (1994).

2. Nobes, C. D. & Hall, A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235–1244 (1999).

3. Manser, E. & Lim, L. Roles of PAK family kinases. Prog. Mol. Subcell. Biol. 22, 115–133 (1999).

4. Arias-Romero, L. E. & Chernoff, J. A tale of two Paks. Biol. Cell 100, 97–108 (2008).

5. Chenette, E. J., Mitin, N. Y. & Der, C. J. Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity. Mol. Biol. Cell 17, 3108–3121 (2006).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers;Cancers;2024-09-05

2. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways;International Immunopharmacology;2024-09

3. PAK4 phosphorylates and inhibits AMPKα to control glucose uptake;Nature Communications;2024-08-10

4. Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy;Bioorganic Chemistry;2024-08

5. PAK4-targeted PROTACs in clear cell renal cell carcinoma: a two-for-one targeted and immune therapy?;eBioMedicine;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3